NCCN Guidelines Insights: Kidney Cancer, Version 2.2020
2019 · Journal of the National Comprehensive Cancer Network · 289 citations
https://doi.org/10.6004/jnccn.2019.0054
N
Naomi B. Haas
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
534
Papers
13.8K
Citations
54
h-index
135
i10-index
Naomi B. Haas is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Renal cell carcinoma treatment & CAR-T cell therapy research & Renal and related cancers. The author has an h-index of 54, co-authored 454 publications.
ORCID: 0000-0001-8907-7968Papers by this author
worksIn vitro hypoxia-conditioned colon cancer cell lines derived from HCT116 and HT29 exhibit altered apoptosis susceptibility and a more angiogenic profile in vivo
2005 · British Journal of Cancer · 71 citations
https://doi.org/10.1038/sj.bjc.6602864
Phase II trial of vorinostat in advanced melanoma
2014 · Investigational New Drugs · 69 citations
https://doi.org/10.1007/s10637-014-0066-9
Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma: Final Overall Survival Analysis of the Phase 3 PROTECT Trial
2021 · European Urology · 62 citations
https://doi.org/10.1016/j.eururo.2020.12.029
Final Overall Survival Analysis of S1500: A Randomized, Phase II Study Comparing Sunitinib With Cabozantinib, Crizotinib, and Savolitinib in Advanced Papillary Renal Cell Carcinoma
2024 · Journal of Clinical Oncology · 33 citations
https://doi.org/10.1200/jco.24.00767
Association between age and sex and mortality after adjuvant therapy for renal cancer
2019 · Cancer · 18 citations
https://doi.org/10.1002/cncr.31955
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat